Johnson & Johnson seeks regulator nod for vax trials in 12-17 age group in India

0
23

हमारे व्हाट्सएप ग्रुप से जुड़े

The American-based pharma major Johnson & Johnson (J&J) has applied to the Central Drugs Standard Control Organisation (CDSCO) for permission to conduct a vaccine trial of the Covid-19 single shot Janssen vaccine in India on children of 12-17 age group.

Facebook Comments Box